We serve Chemical Name:(r)-(+)-1-benzyloxy-butane-2-ol CAS:128821-01-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:(r)-(+)-1-benzyloxy-butane-2-ol
CAS.NO:128821-01-2
Synonyms:(r)-(+)-1-benzyloxy-butane-2-ol
Molecular Formula:C11H16O2
Molecular Weight:180.24400
HS Code:2909499000
Physical and Chemical Properties:
Melting point:N/A
Boiling point:280.7ºC at 760 mmHg
Density:1.023 g/cm3
Index of Refraction:
PSA:29.46000
Exact Mass:180.11500
LogP:1.97410
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like (r)-(+)-1-benzyloxy-butane-2-ol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(r)-(+)-1-benzyloxy-butane-2-ol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(r)-(+)-1-benzyloxy-butane-2-ol Use and application,(r)-(+)-1-benzyloxy-butane-2-ol technical grade,usp/ep/jp grade.
Related News: Beijing will strengthen its monitoring of overseas drug market and collect global prices for imported medicines, Friday��s guideline said. (r)-(+)-1-benzyloxy-butane-2-ol manufacturer The program will run alongside our ongoing Phase 3 INSPIRE Trial, and is expected to continue until commercial launch in such countries. (r)-(+)-1-benzyloxy-butane-2-ol supplier As part of the agreement, ICIG will enter into a 5-year supply contract to provide Genzyme with materials needed for the production of eliglustat tartrate, an investigational treatment for Gaucher disease Type 1 that is currently in Phase III clinical trials. (r)-(+)-1-benzyloxy-butane-2-ol vendor With the improvement of people’s living standards and the aging degree, the demand for medicines has been increasing for a long time. Therefore, the transfer from finished medicines to bulk medicines has greatly promoted the demand for bulk medicines. (r)-(+)-1-benzyloxy-butane-2-ol factory The program will run alongside our ongoing Phase 3 INSPIRE Trial, and is expected to continue until commercial launch in such countries.